Research Design Service: East Midlands
National Institute for Health Research

Latest News

NIHR Clinical Research Network to support broader range of research studies

  Created on Monday, 08 Jan 2018. Posted in News Items

The NIHR Clinical Research Network (CRN) will be extending support into health and social care research taking place in non-NHS settings.

The change to the policy will mean the CRN can support research conducted outside of NHS settings, such as studies running in care homes or in hospices, which will answer important questions for those patient populations.  The CRN will also be able to better support research into public health, for example in schools and other community settings.

This change to the ‘Eligibility Criteria for NIHR Clinical Research Network Support’ policy is a way in which the NIHR is addressing the evolving health and care landscape and the changing needs of people and patients.

Phased rollout
The CRN will monitor the implementation of this policy change over a 12-month period, with a phased rollout from 1 January 2018.

Initially, CRN support will be extended to:

  • Public health research studies outside of NHS settings
  • Social care research studies outside of NHS settings, which are funded by the NIHR School for Social Care Research
  • Other studies taking place outside of NHS settings e.g. hospices

NIHR 2018 themed call: ‘Promotion of good mental health and the prevention or treatment of mental ill health’ across the whole life course

  Created on Monday, 11 Dec 2017. Posted in News Items

NIHR is welcoming proposals for clinical and applied health research that evaluate healthcare interventions, health services, social care or public health measures operating at either the individual, or the population level. Issues of particular interest include proposals that utilise new digital health technologies or investigate their effects

The remit for this call includes conditions listed in the Health Research Classification System (HRCS) category ‘Mental Health’. Studies may include individuals with co-morbidities included in HRCS category ‘Neurological’, provided the main focus remains the mental health condition. 

Applications are encouraged that include geographic populations with high disease burden which have been historically under-served by NIHR research activity. Relevant information is available as a guide for applicants (2015 Compendium).

Applicants should justify the importance of their proposed research and identify how these support aspirations for research in mental health set out in the Five Year Forward View For Mental Health and the ‘Framework for Mental Health Research in the United Kingdom’ led by the Department of Health.

For more information please see the specification document.
Participating Programmes:

  • Efficacy and Mechanism Evaluation (EME)
  • Health Services and Delivery Research (HS&DR)
  • Health Technology Assessment (HTA)
  • Invention for Innovation (i4i)
  • Programme Grants for Applied Research (PGfAR
  • Public Health Research programme (PHR)
  • Research for Patient Benefit (RfPB)
  • Research Professorships
  • Clinician Scientist

Pre-call announcement: ESRC-NIHR dementia research initiative 2018 – prevention, interventions and care delivery

  Created on Monday, 27 Nov 2017. Posted in News Items | Funding

In 2012, NIHR and the Economic and Social Research Council (ESRC) collaborated to fund a £20 million social science dementia research initiative.  Building on the success of the first initiative, NIHR and ESRC will soon announce a new initiative, making up to £16.5 million available for social science research in dementia prevention, interventions and care delivery.

The intention of the initiative is to fund large grants which will be national or international focal points for social science research in dementia.  Applications are expected to be between £2 million and £5 million (100% full economic cost) for a duration of three to five years, and must start in January 2019.

It is expected that proposals will be invited in the following areas:

  • Prevention based on an understanding of socio-economic and environmental risk or protective factors and how best to effect changes in behaviour in order to lessen the risk of developing dementia.
  • Social interventions to slow cognitive decline and promote social inclusion, carer involvement, carer support and quality of life in dementia, underpinning cost effective care models tailored for the population in need.
  • Delivery of interventions looking across care settings, care givers and care providers to deliver the right set of care arrangements in the most appropriate place at the right time.

New NIHR nursing strategy released

  Created on Tuesday, 24 Oct 2017. Posted in News Items

A new strategy for research nurses has been published by the National Institute for Health Research that runs up to 2020. Innovation and the use of digital technology, including research nurses being active learners and becoming ‘digital natives’, is one of four key priorities in the strategy. Other priorities include creating a culture in clinical research that is patient and public focused, developing leaders in the profession and improving awareness of the contribution and impact of clinical research nursing.


Changes to consent for children in clinical trials from May 2018

  Created on Monday, 11 Sep 2017. Posted in News Items

A change in the EU Directive 95/46/EC General Data Protection Regulation (GDPR) affects consent conditions for use of data from children within clinical trials where the data is considered identifiable personal data.

Currently, trials may use an opt-out strategy for parents (negative assent).  When the new directive comes into force in May 2018, positive parent assent will be needed to process the data.

Researchers who think their study protocols may be affected should contact their sponsors for more information and advice.


NIHR signs up to WHO initiative on trial registration

  Created on Thursday, 07 Sep 2017. Posted in News Items

NIHR is the latest research funder to sign up to an international joint statement, developed by the World Health Organization (WHO), pledging to ensure clinical trials will be both registered and their results released.

The pledge, is in line with NIHR's existing policy on Adding Value in Research, and will mean that all fully funded studies will be required to register in a publicly accessible database and make sure all results are disclosed in a timely way.


NIHR Business of Discovery podcast: 'Role of the funder'

  Created on Thursday, 07 Sep 2017. Posted in News Items

The latest NIHR Clinical Research Network 'Business of Discovery' podcast is entitled 'The Role of the Research Funder' and includes an interview with the British Heart Foundation Medical Director Professor Sir Nilesh Samani. The short audio interview explores how research is funded and what the role of a research funder entails. Listen here. 


Health Research Authority (HRA) releases six eLearning modules (ethics and governance)

  Created on Tuesday, 18 Jul 2017. Posted in News Items

The modules are relevant to all four nations of the UK and cover key areas of research regulation. The first three topics to be released are:

Three further modules concerning research involving human tissue, research involving exposure to ionising radiation and confidentiality and information governance considerations in research, are to be released soon.

The eLearning modules will help the research community to better understand the standards that are expected for the conduct of research, supporting applicants to produce better applications that are less likely to raise queries – and get studies up and running quicker.


Electronic vs ink signatures in research approval documents – HRA clarification

  Created on Tuesday, 18 Jul 2017. Posted in News Items


Animation expalins HRA Approval

  Created on Tuesday, 20 Jun 2017. Posted in News Items | Design Tips

HRA Approval is the new process for the NHS in England that brings together the assessment of governance and legal compliance, undertaken by dedicated HRA staff, with the independent REC opinion provided through the UK Health Departments’ Research Ethics Service.  It replaces the need for local checks of legal compliance and related matters by each participating organisation in England.